Treatment of Stage IB to III Nasopharyngeal Carcinoma: CSCO-ASCO Guideline Update
Year: 2026
Type: article
Source: Journal of Clinical Oncology
DOI: 10.1200/jco-26-02648
Authors: Yu-Pei Chen, Nofisat Ismaila, Shao Hui Huang, Wei Jiang, Brigette Ma, Robert Haddad, Quynh-Thu Le, A. Dimitrios Colevas, Kevin Harrington, Sue S. Yom, Brian O'Sullivan, Anthony T.C. Chan, Annie Chan, Nancy Lee, Anne W.M. Lee, Jun-Lin Yi, Chao-Su Hu, Kun-Yu Yang, Qin Lin, Alexander C. Whitley, Jin-Ching Lin, Shu Wing Jack Lam, Yosephtri Siahaan, Melvin L.K. Chua, Jun Ma, Ying Sun
Institutions: Sun Yat-sen University, Sun Yat-sen University Cancer Center, Chinese Society of Clinical Oncology, State Key Laboratory of Oncology in South China, American Society of Clinical Oncology, University of Toronto, Princess Margaret Cancer Centre, Chinese University of Hong Kong, Dana-Farber Cancer Institute, Stanford Medicine, Stanford University, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, University of California, San Francisco, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, University of Hong Kong - Shenzhen Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Fudan University Shanghai Cancer Center, Wuhan Union Hospital, Zhongshan Hospital of Xiamen University, Changhua Christian Hospital, National University of Singapore, Duke-NUS Medical School, National Cancer Centre Singapore
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7225752293
FWCI:
Cites:
Cited by:
Related to: